Singapore Biopharma APAC Confex 2027

23–24 March 2027 at Sands Expo & Convention Centre, Singapore. Biopharma Asia Pacific Conference, Exhibition & Awards 2027 brings specialist conferences, an exhibition, partnering, networking and awards together around drug development and manufacturing across Asia-Pacific. The organiser presents it as a decision-maker-focused event spanning six co-located conferences. For visitors, the value is in connecting technical, clinical, manufacturing and commercial perspectives; for suppliers, it is a place to explain capabilities and explore where they fit in the region’s biopharma ecosystem.

Why Singapore Biopharma APAC Confex matters

Follow the whole development-to-manufacturing chain

The programme joins topics that are often considered separately: biologics manufacturing, clinical trials, advanced therapeutic modalities and supply chains. This makes it relevant to professionals assessing how development choices affect production readiness, quality, sourcing and distribution.

Compare several specialist perspectives

The six co-located conferences cover Biologics Manufacturing Asia, Clinical Trials Festival Asia, BioSupply Chain Asia, ADC Asia Congress, Cell & Gene Therapy World Asia, and Oligos & Peptides World Asia. Attendees can use this breadth to identify where their work overlaps with adjacent functions, while still prioritising the specialist sessions most relevant to their role.

Use the exhibition and partnering with a purpose

The organiser describes a focused exhibition, partnering and curated networking alongside the conference programme. Its 2027 event page advertises 2,000+ attendees, 700+ companies, 250+ speakers, 30+ interactive sessions and 72+ networking hours. Treat these as the organiser’s published event figures, not a guarantee of particular meetings or outcomes.

Who should visit Singapore Biopharma APAC Confex?

Biopharma research and development leaders

Useful if you are assessing therapeutic platforms, development pathways or collaboration models. Compare perspectives across biologics, ADCs, cell and gene therapies, and oligonucleotides and peptides. Identify which modalities and development decisions matter most to your pipeline.

Manufacturing, process and quality professionals

Focus on biologics manufacturing and technologies or services that support production. Prepare questions about process fit, scale-up, quality evidence, technical integration and requirements that need validation within your organisation.

Clinical development and trial-supply teams

The clinical development and biopharma supply-chain strands offer a reason to compare trial operations with the needs of complex therapies. Map the operational issues you need to solve, then prioritise relevant sessions and conversations with service providers.

Executives, procurement teams and decision-makers

The organiser positions the event for decision-makers. Use the cross-functional setting to compare strategic options and understand how development, manufacturing and supply-chain decisions connect. Confirm the current programme before fixing a session plan.

Technology innovators, CDMOs and solution providers

The organiser describes technology innovators, CDMOs and solution providers as part of the event community. Exhibitors and prospective partners may use the exhibition and partnering format to explain capabilities, assess technical fit and identify evidence a prospective customer would require.

What can you find at Singapore Biopharma APAC Confex?

Biologics manufacturing

Manufacturing-focused discussions and the exhibition are relevant to professionals working on biologics production, process development and supporting technologies. Focus on process requirements and the technical documentation needed for evaluation.

Clinical development and trial operations

The Clinical Trials Festival Asia conference strand creates a dedicated route into clinical development topics. Visitors can prioritise questions about trial or service needs and compare relevant approaches.

Advanced therapeutic modalities

• Antibody-drug conjugates (ADCs)
• Cell and gene therapy
• Oligonucleotides and peptides

These strands connect emerging modalities with development, manufacturing and supply-chain considerations. Check the current programme for specific sessions and activities.

Biopharma supply chain

BioSupply Chain Asia gives supply-chain professionals a dedicated conference strand. Consider how sourcing, product handling, distribution and operational resilience affect your organisation’s modalities and markets.

What makes Singapore Biopharma APAC Confex different?

Its defining feature is the co-location of six specialist conferences with an exhibition and professional networking. The event connects biologics manufacturing, clinical trials, ADCs, cell and gene therapy, oligonucleotides and peptides, and supply chains. This breadth can help attendees identify cross-functional questions and compare perspectives. The organiser also describes partnering, curated networking and awards. Check the latest official programme for specific sessions, meetings and award details.

What should you try to achieve during Singapore Biopharma APAC Confex?

If you work in R&D or therapeutic development

Choose one modality or development decision to investigate. Record the evidence, capabilities and next technical questions each conversation raises.

If you work in manufacturing, process development or quality

Identify the process or capability gap you need to address. Compare technologies and services against scale, integration, quality and validation requirements.

If you work in clinical development or supply chain

Map one operational challenge across the trial or product lifecycle. Use the relevant specialist conference to compare approaches and record dependencies for follow-up.

If you are an exhibitor or solution provider

Define the customer problem your offering addresses and the proof a decision-maker needs. Prepare a concise explanation of technical fit, implementation requirements and the questions to resolve after the event.

How to prepare before Singapore Biopharma APAC Confex

1. Set a focused objective. Decide whether your priority is scientific insight, manufacturing capability, clinical development, supply chain, partnerships or market understanding.
2. Review the six conference strands. Mark sessions relevant to your role and leave time for the exhibition and conversations. Recheck the organiser’s agenda for updates.
3. Prepare technical questions. Ask about application fit, process or trial requirements, evidence, integration, quality expectations and information needed for evaluation.
4. Plan conversations. Group prospective contacts into essential, useful and optional. Prepare a short introduction describing your modality, role, challenge and desired follow-up.
5. Check registration and event arrangements. Verify current ticket options, session schedule and access details with the organiser before travelling.

How to make the most of the exhibition and networking

Use each conversation to gather comparable information rather than collecting brochures without a decision in mind. Record: organisation or capability → relevant modality → evidence to request → fit or gap → next action. For manufacturing technology, note the process stage supported, operating requirements to validate and documentation your technical and quality colleagues need.

For partnering conversations, state your objective clearly and distinguish exploratory interest from qualified technical or commercial fit. Confirm how the advertised partnering and curated networking formats operate for 2027.

Beyond the Singapore Biopharma APAC Confex exhibition floor

The event combines six conference strands with a focused exhibition, partnering, curated networking and awards. The official page lists speaker profiles and provides a programme and agenda page. Use the current agenda to select sessions and confirm changes with the organiser.

How long should you plan for Singapore Biopharma APAC Confex?

The event runs across two days. A single-day visit may suit attendees with one defined conference strand or a short list of exhibition conversations. Consider both days if your priorities span modalities or combine sessions, supplier discussions and partnering. Leave time for follow-up notes.

After Singapore Biopharma APAC Confex: where the value starts

Sort contacts into immediate technical follow-up, potential collaboration and general market intelligence. Record the question to resolve and the information needed next: process data, service scope, quality documentation, trial capabilities or supply-chain requirements. Compare responses against your original objective before internal review, involving scientific, regulatory, quality or commercial colleagues as appropriate.

Who should consider exhibiting at Singapore Biopharma APAC Confex?

Technology innovators, CDMOs and solution providers serving biologics manufacturing, clinical development, advanced modalities or biopharma supply chains may find the audience relevant. Before committing, define the decision-makers you need to reach, the application you can demonstrate and the evidence attendees can take away. Evaluate the organiser’s current exhibitor information for format and terms; exhibition participation does not guarantee leads or commercial results.

Singapore Biopharma APAC Confex visitor checklist

Before

• ☐ Select the conference strand and professional objective that matter most.
• ☐ Review the latest agenda, registration options and event arrangements.
• ☐ Prepare technical or clinical questions and a short introduction.

During

• ☐ Record capability, modality, evidence and next action for useful conversations.
• ☐ Balance relevant sessions with exhibition and partnering priorities.
• ☐ Capture notes and clarify follow-up responsibilities.

After

• ☐ Send specific follow-up questions and request material needed for evaluation.
• ☐ Share findings with relevant scientific, manufacturing, clinical, quality or procurement colleagues.
• ☐ Review contacts against your original objective.

Is Singapore Biopharma APAC Confex worth visiting?

It is most relevant to professionals working across biopharma R&D, biologics manufacturing, clinical development, advanced modalities or supply chains. The six co-located conferences, exhibition and partnering formats offer broad perspectives, so a focused agenda matters. Visitors with a clear technical, operational or strategic question are better placed to identify useful sessions and conversations than those who try to cover every strand.

Singapore Biopharma APAC Confex 2027 at a glance

The official page states the event dates and venue. Use current organiser information for registration and detailed agenda.

Plan your Singapore visit with purpose

Choose the questions and conversations that will make the two conference days useful, then leave time to reflect on what you learn. Let your professional priorities determine which strands you follow.

Biopharmaceutical opportunities in Singapore

Market size and demand

Singapore’s Economic Development Board reports that biopharmaceutical facilities manufactured products worth S?.1 billion in 2024. EDB also reports more than 60 manufacturing plants, spanning small-molecule APIs, biologics and newer modalities including cell therapies and ADCs. This is manufacturing output, not the value of the market available to a new supplier.

Market drivers and commercial opportunities

The manufacturing base and its modality range are relevant to the event’s biologics, ADC, cell and gene therapy, oligonucleotide and peptide, and supply-chain themes. EDB describes public-private programmes supporting manufacturing innovation.

• Manufacturing technology and services: suppliers may assess how process equipment, development services or CDMO capabilities fit local production needs. Qualification, quality evidence and site-specific requirements remain barriers.
• Advanced modalities: companies in cell therapies and ADCs may explore capability requirements in light of documented manufacturing activity. The output figure does not establish demand for any particular supplier.
• R&D and operational partnerships: participants may investigate connections between development, manufacturing and supply-chain needs. Validate each opportunity technically and commercially.

Regulations and market-entry conditions

Singapore’s Health Sciences Authority states that overseas manufacturers seeking to register therapeutic products may be subject to a GMP conformity assessment. Requirements depend on the product and manufacturer; check current HSA guidance and the applicable registration pathway.

What this means for exhibitors and visitors

Exhibitors may assess the relevance of their technologies or services to Singapore’s manufacturing base and clarify qualification questions. Visitors may compare suppliers, development services and manufacturing approaches for their modalities. Neither event participation nor national output guarantees customer access, contracts or commercial success.

Discover Singapore

The Marina Bay area combines waterfront public spaces and contemporary attractions. The event venue is in Singapore itself, so visitors can consider city attractions around their conference schedule.

Gardens by the Bay

A garden attraction in Marina Bay known for its Supertrees and conservatories.

Merlion Park

A waterfront park in Marina Bay with views across the bay.

Use the event days for the conference and exhibition, then fit city visits around the schedule and other professional commitments.